Atlas Trials

Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study

Clinical trial NCT05653193 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05653193
Sponsor
Manchester University NHS Foundation Trust
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Pulmonary AspergillosisAspergillosis
Start date
2024-05-17
Primary completion
2026-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.